Skip to main content
. 2022 Oct 21;45(6):3759–3770. doi: 10.1007/s10143-022-01884-3

Table 3.

Clinical and radiological analysis between surgical (group A) and endovascular (group B) groups of patients

162 pts Group A Surgical series, 118 pts Group B Endovascular series, 44 p-value
Mean age 47.87 min = 18 max = 72 SD = 10.59 53.98 min = 10 max = 86 SD = 20.2
Female 60/118, 50.8% 39/86, 88.6%  < 0.05
Location Posterior circulation, 8 pts, 6.8% Posterior circulation, 8 pts, 18.2%
ICA petrous, 3 pts, 2.5% ICA petrous, 0%
ICA cavernous, 25 pts, 21.2% ICA cavernous, 16 pts, 36.4%
ICA clinoid/sovraclinoid, 49, 38.1% ICA clinoid/sovraclinoid, 19, 43.2%
MCA, 22 pts, 18.6% MCA, 1 pt, 2.3%
AcoA, 15 pts, 12.7% AcoA, 0%
Neck No proper neck, 30 pts, 25.4% No proper neck, 4 pts, 9.1% 0.02
Neck <  = 4 mm, 65 pts, 55.1% Neck <  = 4 mm, 11 pts, 25% 0,01
Neck > 4 mm, 11 pts, 9.3% Neck > 4 mm, 29 pts, 65.9%  < 0.01
Neck calcified 12, 10.2% 0% 0.19
Shape Dissected = 0% Dissected = 20, 45.5%  < 0.05
Saccular = 93, 78.8% Saccular = 22, 50% 0.07
Saccular = 93, 78.8% Saccular = 22, 50%  < 0.05
Thrombosis  < 50% = 34, 28.8%  < 50% = 12, 27.3% 0.51
 > 50% = 2, 1.7%  > 50% = 2, 4.5% 0.3
No thrombosis = 84, 71.2% No thrombosis = 32, 72.7% 0.51
Debut Incidental = 10, 8.5% Incidental = 1, 2.3% 0.15
SAH symptoms = 28, 23.7% SAH symptoms = 5, 11.4% 0.06
Seizure = 12, 10.2% Seizure = 0% 0.02
TIA/ischemia = 17, 14.4% TIA/ischemia = 0% 0.03
Headache = 0% Headache = 13, 29.5%  < 0.01
Mass effect/focal deficit = 50, 42.7% Mass effect/focal deficit = 25, 56.8% 0.07
MRS pre-op  < 2 = 67, 56.8%  < 2 = 100%  < 0.01
 > 2 = 51, 43.2%
Hunt-Hess HH 3–4 = 7, 5.9% HH 3–4 = 9, 20.5%  < 0.01
HH 1–2 = 22, 18.6% HH 1–2 = 1, 2.3% 0.004
HH 0 = 89, 75.4% HH 0 = 34, 77.3% 0.49